ArticleGlobal epidemiology2025
An AI assistant for critically assessing and synthesizing clusters of journal articles.
Article in Global epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current large language models (LLMs) face significant challenges in attempting to synthesize and critically assess conflicting causal claims in scientific literature about exposure-associated health effects. This paper examines the design and performance of AIA2, an experimental AI system (freely available at http://cloud.cox-associates.com/) designed to help explore and illustrate potential applications of current AI in assisting analysis of clusters of related scientific articles, focusing on causal claims in complex domains such as epidemiology, toxicology, and risk analysis. Building on an earlier AI assistant, AIA1, which critically reviewed causal claims in individual papers, AIA2 advances the approach by systematically comparing multiple studies to identify areas of agreement and disagreement, suggest explanations for differences in conclusions, flag methodological gaps and inconsistencies, synthesize and summarize well-supported conclusions despite conflicts, and propose recommendations to help resolve knowledge gaps. We illustrate these capabilities with a case study of formaldehyde exposure and leukemia using a cluster of four papers that feature very different approaches and partly conflicting conclusions. AIA2 successfully identifies major points of agreement and contention, discusses the robustness of the evidence for causal claims, and recommends future research directions to address current uncertainties. AIA2's outputs suggest that current AI can offer a promising, practicable approach to AI-assisted review of clusters of papers, promoting methodological rigor, thoroughness, and transparency in review and synthesis, notwithstanding current limitations of LLMs. We discuss the implications of AI-assisted literature review systems for improving evidence-based decision-making, resolving conflicting scientific claims, and promoting rigor and reproducibility in causal research and health risk analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.